Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DP-b99 in Acute High-risk Pancreatitis
NCT02025049Phase 2Terminated
- Sponsor
- D-Pharm
- Start
- Dec 2013
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of DP-b99 in acute pancreatitis (AP), sponsored by D-Pharm. Started Dec 2013; status: terminated.
02
Drugs
DP-b99
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on NCT02025049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02025049.